Literature DB >> 8049419

The cellular biology of the Reed-Sternberg cell.

F G Haluska1, A M Brufsky, G P Canellos.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8049419

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Epstein-Barr virus-associated Hodgkin's disease following renal transplantation.

Authors:  Jung-Hye Choi; Myung-Ju Ahn; Young-Ha Oh; Sang-Woong Han; Ho-Jung Kim; Young-Yeul Lee; In-Soon Kim
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

Review 2.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 3.  [Pathogenesis and therapy of Hodgkin lymphoma].

Authors:  H Tesch; H Bohlen; J Wolf; A Engert
Journal:  Med Klin (Munich)       Date:  1998-02-15

4.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

Authors:  H Kanzler; R Küppers; M L Hansmann; K Rajewsky
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

5.  Mitochondrial Generated Redox Stress Differently Affects the Endoplasmic Reticulum of Circulating Lymphocytes and Monocytes in Treatment-Naïve Hodgkin's Lymphoma.

Authors:  Cecilia Marini; Vanessa Cossu; Matteo Bauckneht; Sonia Carta; Francesco Lanfranchi; Francesca D'Amico; Silvia Ravera; Anna Maria Orengo; Chiara Ghiggi; Filippo Ballerini; Paolo Durando; Sabrina Chiesa; Alberto Miceli; Maria Isabella Donegani; Silvia Morbelli; Silvia Bruno; Gianmario Sambuceti
Journal:  Antioxidants (Basel)       Date:  2022-04-11

6.  B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.

Authors:  W C Vooijs; H G Otten; M van Vliet; A J van Dijk; R A de Weger; M de Boer; H Bohlen; A Bolognesi; L Polito; G C de Gast
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and Review of the Literature.

Authors:  Elham Vali Betts; Denis M Dwyre; Huan-You Wang; Hooman H Rashidi
Journal:  Case Rep Hematol       Date:  2017-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.